English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Receptor tyrosine kinases as targets for anticancer drugs

Zwick, E., Bange, J., & Ullrich, A. (2002). Receptor tyrosine kinases as targets for anticancer drugs. Trends in Molecular Medicine, 8(1), 17-23.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Trends Mol. Med

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Zwick, E.1, Author
Bange, J.2, Author           
Ullrich, A.2, Author           
Affiliations:
1External Organizations, ou_persistent22              
2Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172              

Content

show
hide
Free keywords: -
 Abstract: Receptor tyrosine kinases (RTKs) are the primary mediators of the signaling network that transmit extracellular signals into the cell. Gene amplification and/or overexpression of RTK proteins or functional alterations caused by mutations in the corresponding genes or abnormal autocrine-paracrine growth factor loops contribute to constitutive RTK signaling, ultimately resulting in the manifestation of dysregulated cell growth and cancer. The mechanism of uncontrolled RTK signaling that leads to cancer has provided the rationale for anti-RTK drug development. Strategies towards the prevention and interception of RTK signaling include monoclonal antibodies, small-molecule inhibitors, immunotoxins and antisense oligonucleotides.

Details

show
hide
Language(s): eng - English
 Dates: 2002-01
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 35072
ISI: 000173187000004
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Trends in Molecular Medicine
  Alternative Title : Trends Mol. Med
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 8 (1) Sequence Number: - Start / End Page: 17 - 23 Identifier: ISSN: 1471-4914